Complicaciones extrapulmonares de la enfermedad por COVID-19
DOI:
https://doi.org/10.35839/repis.4.4.775Palabras clave:
COVID-19, SARS-CoV-2, complicaciones, manifestaciones neurológicasResumen
La infección por SARS-CoV-2 es la enfermedad emergente más importante del presente siglo. Desde su aparición hasta la actualidad ha ocasionado casi un millón de muertes en todo el mundo, convirtiéndose en una verdadera amenaza para la salud pública. Por tal motivo las nuevas revisiones y estudios científicos al respecto resultan sumamente importantes. De igual manera se sabe que la afección principal por este virus está confinado al sistema respiratorio. Sin embargo, aún existen aspectos desconocidos de la enfermedad y dentro de ellas se encuentran las complicaciones extrapulmonares. La presente revisión intenta resumir todo lo conocido al momento respecto a la enfermedad y sus complicaciones neurológicas, hematológicas. cardiológicas, renales y hepáticas.
Descargas
Citas
-Soumya, R.S., Unni, T.G. & Raghu, K.G. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Cardiovasc Drugs Ther (2020). https://doi.org/10.1007/s10557-020-07073-y
-Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-847. doi:10.1002/ajh.25829
-Shao M, Li X, Liu F, Tian T, Luo J, Yang Y. Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: A systematic review and meta-analysis of 40 studies and 24,527 patients [published online ahead of print, 2020 Jul 31]. Pharmacol Res. 2020;161:105107. doi:10.1016/j.phrs.2020.105107
-Kunutsor SK, Laukkanen JA. Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis. J Infect. 2020 Sep;81(3):e72-e74. doi: 10.1016/j.jinf.2020.06.043. Epub 2020 Jun 21. PMID: 32579984; PMCID: PMC7306105.
- Leonardi, M., Padovani, A. & McArthur, J.C. Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol 267, 1573–1576 (2020). https://doi.org/10.1007/s00415-020-09896-z
Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069.
Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–5068.
-Mao L, Jin H, Wang M, et al. Manifestaciones neurológicas de pacientes hospitalizados con enfermedad por coronavirus 2019 en Wuhan, China. JAMA Neurol. 2020 doi: 10.1001 / jamaneurol.2020.1127.
- Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID‐19 neurology: clinical, radiological and laboratory findings. Brain 2020.
-Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191:148-150. doi:10.1016/j.thromres.2020.04.041
Yaghi S, Ishida K, Torres J, et al. SARS-CoV-2 and Stroke in a New York Healthcare System [published correction appears in Stroke. 2020 Aug;51(8):e179]. Stroke. 2020;51(7):2002-2011. doi:10.1161/STROKEAHA.120.030335
-Dogra S, Jain R, Cao M, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis. 2020;29(8):104984. doi:10.1016/j.jstrokecerebrovasdis.2020.104984
-Merkler AE, Parikh NS, Mir S, et al. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza [published online ahead of print, 2020 Jul 2]. JAMA Neurol. 2020;e202730. doi:10.1001/jamaneurol.2020.2730
-Cantador E, Núñez A, Sobrino P, et al. Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients [published online ahead of print, 2020 Jun 9]. J Thromb Thrombolysis. 2020;1-5. doi:10.1007/s11239-020-02176-7
-Hernández-Fernández F, Valencia HS, Barbella-Aponte RA, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description [published online ahead of print, 2020 Jul 9]. Brain. 2020;awaa239. doi:10.1093/brain/awaa239
- Jin M, Tong Q. Rabdomiólisis como posible complicación tardía asociada con COVID-19. Emerg Infect Dis. 2020 doi: 10.3201 / eid2607.200445.
Zhao H, Shen D, Zhou H, Liu J, Chen S. Síndrome de Guillain-Barré asociado con la infección por SARS-CoV-2: ¿causalidad o coincidencia? Lancet Neurol. 2020; 19 : 383–384. doi: 10.1016 / S1474-4422 (20) 30109-5
-Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091.
-Mahammedi A, Saba L, Vagal A, et al. Imaging in neurological disease of hospitalized COVID‐19 patients: an Italian multicenter retrospective observational study. Radiology 2020:201933.
-Chougar L, Shor N, Weiss N, et al. Retrospective observational study of brain magnetic resonance imaging findings in patients with acute SARS‐CoV‐2 infection and neurological manifestations. Radiology 2020:202422
-Fitsiori A, Pugin D, Thieffry C, et al. Unusual microbleeds in brain MRI of Covid‐19 patients. J Neuroimaging 2020. [Epub ahead of print].
-Radmanesh A, Derman A, Lui YW, et al. COVID‐19 ‐associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020:202040.
-Kremer S, Lersy F, de Sèze J, et al. Brain MRI findings in severe COVID‐19: a retrospective observational study. Radiology 2020;16:202222.
-Toscano G, Palmerini F, Ravaglia S, et al. Guillain‐Barré syndrome associated with SARS‐CoV‐2. N Engl J Med 2020;382:2574–2576.
-Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS‐CoV‐2 infection. N Engl J Med. [Epub ahead of print]
-Scullen T, Keen J, Mathkour M, et al. Coronavirus 2019 (COVID‐19)‐associated encephalopathies and cerebrovascular disease: the New Orleans experience. World Neurosurg 2020.
-Brown EG, Chahine LM, Goldman SM, et al. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease [published online ahead of print, 2020 Sep 10]. J Parkinsons Dis. 2020;10.3233/JPD-202249. doi:10.3233/JPD-202249
- Varatharaj A, Thomas N, Ellul MA, et al. Complicaciones neurológicas y neuropsiquiátricas de COVID ‐ 19 en 153 pacientes: un estudio de vigilancia en todo el Reino Unido . Lancet Psychiatry 2020.
-Qianwen Zhao, Meng Meng, Rahul Kumar, Yinlian Wu, Jiaofeng Huang, Yunlei Deng, Zhiyuan Weng, Li Yang,Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis,International Journal of Infectious Diseases,Volume 96,2020,Pages 131-135,ISSN 1201-9712,https://doi.org/10.1016/j.ijid.2020.04.086.
-Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;4:844‐847.
-Madjid M, Safavi‐Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020. 10.1001/jamacardio.2020.1286.
- Li T, Lu H, Zhang W. Clinical observation and management of COVID‐19 patients. Emerg Microbes Infect. 2020;1:687‐690.
-Complicaciones graves de la infección por SARS-CoV-2: mecanismos de acción patógena y opciones terapéuticas [Internet]. cochrane iberoamerica. 2020 [citado 17 septiembre 2020]. Disponible en: https://es.cochrane.org/es/complicaciones-graves-de-la-infecci%C3%B3n-por-sars-cov-2-mecanismos-de-acci%C3%B3n-pat%C3%B3gena-y-opciones
-Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708‐1720. 10.1056/NEJMoa2002032.
- Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.0994.
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061‐1069. 10.1001/jama.20.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497‐506.
- Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid‐19 in critically ill patients in the seattle region ‐ case series. N Engl J Med. 2020. 10.1056/NEJMoa2004500.
- Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID‐19 in Washington State. JAMA. 2020;323(16):1612‐1614.
- Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis [published online ahead of print, 2020 Sep 15]. BMJ Evid Based Med. 2020;bmjebm-2020-111536. doi:10.1136/bmjebm-2020-111536
- Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020;12(7):448-453. doi:10.14740/jocmr4240
- . Qu R, Ling Y, Zhang YH, et al. Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19. J Med Virol. 2020.
- Taneri PE, Gómez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(8):763-773. doi:10.1007/s10654-020-00678-5
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507‐513.
- Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID‐19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020. 10.1097/CM9.0000000000000824.
-Zhou F, Yu T, Du R, et al Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet 2020. 28; 395(10229): 1054–1062.
- Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID‐19 in Wuhan, China. JAMA Cardiol. 2020;e200950. 10.1001/jamacardio.2020.0950.
-Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID‐19). JAMA Cardiol. 2020;e201017. 10.1001/jamacardio.2020.1017.
- National Institute for Health and Care Excellence. NICE guideline [NG171]. COVID-19 rapid guideline: acute myocardial injury. 2020. [Internet]. Acceso 10 de agosto 2020. Disponbible en: https://www.nice.org.uk/guidance/ng171/chapter/4-Managing-myocardial-injury-in-patients-with-suspected-or-confirmed-COVID-19
-Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426:450–
Groß S, Jahn C, Cushman S, Bär C, Thum T. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: from basic science to clinical implications. J Mol Cell Cardiol. 2020;144:47–53.
- Yu JN, Wu BB, Yang J, Lei XL, Shen WQ. Cardio-Cerebrovascular Disease is Associated With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis [published online ahead of print, 2020 Aug 27]. Biol Res Nurs. 2020;1099800420951984. doi:10.1177/1099800420951984
- American Heart Association. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. 2020. [Internet]. Acceso 10 de agosto 2020. https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician?utm_campaign=sciencenews19-20&utm_source=science-news&utm_medium=phd-link&utm_content=phd03-21-20.
-Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14:247–50.
-Böhm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM. Coronavirus disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol. 2020;27:1–14.
-Coll-Muñoz Y, Valladares-Carvajal F, González-Rodríguez C. Infarto agudo de miocardio. Actualización de la Guía de Práctica Clínica. Revista Finlay [revista en Internet]. 2016 [citado 2020 Sep 20]; 6(2):[aprox. 20 p.].
-Nan J, Jin YB, Myo Y, Zhang G. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies. J Geriatr Cardiol. 2020;17(4):221–3.
-Orrico J. Coronavirus and heart. 2020. https://news.harvard.edu/ gazette/story/2020/04/covid-19s-consequences-for-the-heart/. Accessed 14 Apr 2020.
-Guo T, Fan Y, Chen M, Wu X, Zhang L, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):1–8. 38.
-Shi S, Qin M, Shen B, Cai Y, Liu T, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810.
- Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372-2374. doi:10.1056/NEJMc2010419.
-Shao M, Li X, Liu F, Tian T, Luo J, Yang Y. La lesión renal aguda se asocia con infección grave y muerte en pacientes con COVID-19: una revisión sistemática y metanálisis de 40 estudios y 24.527 pacientes [publicado en línea antes de la impresión, 31 de julio de 2020]. Pharmacol Res . 2020; 161: 105107. doi: 10.1016 / j.phrs.2020.105107.
-. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect 2020 PubMed PMID: 32240670. Pubmed Central PMCID:PMC7118526. Epub 2020/04/03.
- Wong YJ, Tan M, Zheng Q, et al. A systematic review and meta-analysis of the COVID-19 associated liver injury [published online ahead of print, 2020 Aug 31]. Ann Hepatol. 2020;S1665-2681(20)30161-7. doi:10.1016/j.aohep.2020.08.064
Descargas
Publicado
Cómo citar
Número
Sección
